Hits: 1063
First HER2 directed medicine approved for patients with gastric cancer in a decade
TOKYO, Japan & MUNICH, Germany & BASKING RIDGE, NJ USA I January 15, 2021 I Daiichi Sankyo Company, Limited (hereafter, Daiichi Sankyo) and AstraZeneca’s
ENHERTU
® (fam-trastuzumab deruxtecan-nxki) has been approved in the U.S. for the treatment of adult patients with locally advanced or metastatic HER2 positive gastric or gastroesophageal junction (GEJ) adenocarcinoma who have received a prior trastuzumab-based regimen.
In the U.S., gastric cancer is more frequently diagnosed in the advanced stage, with only approximately 5% of patients surviving five years.
1,2 Approximately one in five gastric cancers are HER2 positive.
UAE s FAB issues 1.5 billion yuan five-year bond
SECTIONS
Last Updated: Jan 12, 2021, 03:21 PM IST
Share
Synopsis
The majority of investors comprised both onshore Taiwanese and Asian investors, and was well diversified amongst life insurers, banks, fund managers and securities houses, it said in a statement.
DUBAI: First Abu Dhabi Bank, UAE s biggest lender, said on Tuesday it has issued a 1.5 billion yuan ($232.05 million) five-year bond at 3.15%, the year s first yuan debt in the Formosa bond market.
The majority of investors comprised both onshore Taiwanese and Asian investors, and was well diversified amongst life insurers, banks, fund managers and securities houses, it said in a statement.